logo-en
  • Home
  • Companies
  • Investors
    • Home
  • FinTech Hub
  • News
LoginRegister
  • english iconEnglish
  • english iconArabic
  1. Mubasher News
  2. BioSapien collects $5.5 million to boost clinical trials in UAE

BioSapien collects $5.5 million to boost clinical trials in UAE

NOHA.GAD
Dec 15, 2024
BioSapien secured $5.5 million in a pre-series A round to boost clinical trials of its flagship product MediChip in the UAE

Abu Dhabi - Sharikat Mubasher: BioSapien, the patented drug delivery platform treating cancer locally, raised $5.5 million in a pre-series A funding round led by Global Ventures, with participation from Dara Holdings.

BioSapien will allocate the funds to boost the clinical trials of its flagship product MediChip in the UAE, increase product development and manufacturing, and onboard new talent, the company announced in a recent press release.

MediChip is a drug delivery, 3D-printed, slow-release delivery platform attachable to any tissue with minimal systemic side effects.

BioSapien is developing its platform for clinical trials in colorectal cancer patients, with the scope to branch out to other cancers (pancreatic, lung), and non-cancer indications such as opioids, hormones, biologics, and cell and gene therapies.

CEO and Founder of BioSapien Khatija Ali said: “We are delighted to announce our pre-Series A fundraise to accelerate our clinical trials and product development. There is a high unmet need for sustained drug release with minimal side effects in healthcare with over 30% of chemotherapy patients enduring severe side effects, often resulting in reduced or halted treatment.”

She clarified that BioSapien’s vision is to provide on-the-go therapy and treat cancer locally, leveraging its innovative technology to reduce roadblocks and increase quality of life during treatment.

Meanwhile, Noor Sweid, Founder and Managing Partner of Global Ventures, commented: “BioSapien’s drug delivery technology utilizes advanced 3D printing and epitomizes cost-effective innovation in a market ripe for new solutions with benefits for multiple stakeholders.”

With offices in Abu Dhabi and California, BioSapien aims to treat 1 million patients by 2035, prioritizing patient well-being and reducing healthcare costs.

Tags

Drug delivery
Clinical trials
Cancer treatment
MediChip
Funding round
Share

Attract clients with your ad

Start Now

Trending

Brand Finance names PIF as world’s most valuable SWF brand
Riyadh - Sharikat Mubasher: Saudi Arabia’ Public Investment Fund (PIF) was named the world's most valuable sovereign wealth fund (SWF) brand for the third consecutive year, according to the “Brand Finance Asset Management & Sovereign Wealth Fund 50 2026” report.The report highlighted that the PIF’s brand value is worth $1.2 billion, making it the only SWF valued at more than $1 billion. This was due to growth in advocacy for PIF outpacing that of its peers, with investor willingness to recommend PIF having grown by twice the sector average since 2024.The report valued the brands of the 50 companies surveyed at a combined $74.2 billion, an increase of 7% on 2025. The study, which is the first global benchmark of brand value and strength, was based partly on surveys of institutional investors, asset managers, media and the informed public.It found that PIF’s 2026 “brand strength index” rating rose to 65.4 from 62.9, above the average growth for a SWF, while its brand strength rating rose to AA- from A+ a year ago. The fund scored particularly highly in the “brand value to AUM” metric, with a score of 0.13%, placing it in the upper quartile of all those surveyed.Commenting on this milestone, Loui Kofiah, director of brand strategy and management and acting head of data insights and analytics at PIF, said: “A strong brand value reflects impact, and impact builds trust. And for an investor, trust opens doors. And that matters more than ever as our 2026-2030 strategy aims to unlock synergies in its six ecosystems and bring more partners alongside PIF. The Brand Finance research shows that trust is growing.”PIF’s rising brand value reflects its journey in becoming one of the world’s most influential investors, growing its assets under management from $150 billion in 2015 to over $900 billion by the end of 2025.
Saudi Arabia's Logistics Commercial Registrations Rise 35% in 2026
MUBASHER.SA
Vision Club 2030 to launch 3rd edition of Quroosh program next week
MUBASHER.SA
ADI Foundation partners with Vision Bank to advance banking tokenization
MUBASHER
X2 Ventures supports ALPHA10X’s move to Doha with $1mn investment
MUBASHER

Related News

Funding News
Calendar Icon
Nov 16, 2026
Sabika raises funding to scale precious metals investment platform
Read More
Funding News
Calendar Icon
Nov 15, 2026
Saudi fintech lending to industrial projects reaches SAR 751 mn in 9M
Read More
Funding News
Calendar Icon
Nov 11, 2026
Wafr secures pre-seed funding to develop global Islamic finance platform
Read More
Funding News
Calendar Icon
Nov 10, 2026
Ejari expands its warehouse financing facility with PFG to SAR 187.5 mn
Read More
Funding News
Calendar Icon
Nov 9, 2026
Soter Insure expands Series B with investments from SC Ventures, SBI Group
Read More
Funding News
Calendar Icon
Nov 9, 2026
HUMAIN, Infra sign SAR 2.5 bn deals to scale AI infrastructure
Read More
Funding News
Calendar Icon
Nov 5, 2026
Persona raises $630K pre-seed funding to expand across GCC
Read More

Sharikat Mubasher Newsletter

Get insights and exclusive content from the world of business and finance that you can trust delivered to your inbox

Email is Required
Should be a valid email

Democratizing private equity investments

  • Home
  • Companies
  • Investors
  • FinTech Hub
  • News
  • Contact Us
  • Sitemap
2024 All rights reserved to Sharikat Mubasher